N-(2-((1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-5-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)-4-methoxyphenyl)but-2-ynamide

ID: ALA5200584

PubChem CID: 153531813

Product Number: N609500, Order Now?

Max Phase: Preclinical

Molecular Formula: C34H32Cl2N4O6

Molecular Weight: 663.56

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  CC#CC(=O)Nc1cc(-c2cc3c(cn2)cc(-c2c(Cl)c(OC)cc(OC)c2Cl)c(=O)n3CC)c(OC)cc1N1C[C@H]2C[C@@H]1CO2

Standard InChI:  InChI=1S/C34H32Cl2N4O6/c1-6-8-30(41)38-24-11-21(27(43-3)13-26(24)40-16-20-10-19(40)17-46-20)23-12-25-18(15-37-23)9-22(34(42)39(25)7-2)31-32(35)28(44-4)14-29(45-5)33(31)36/h9,11-15,19-20H,7,10,16-17H2,1-5H3,(H,38,41)/t19-,20-/m1/s1

Standard InChI Key:  VDIDNMGZRIMBKL-WOJBJXKFSA-N

Molfile:  

 
     RDKit          2D

 48 53  0  0  0  0  0  0  0  0999 V2000
    2.8662    0.8267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1523    0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1523   -0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8662   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5802   -0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5802    0.4133    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.2984   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0124   -0.4133    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7306   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2984   -1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5802   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5802   -2.8934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2984   -3.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8662   -1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1523   -2.0667    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.4342   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4342    0.8267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4342    1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1523    2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7160    0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7160   -0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161   -0.4133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161    0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4301    0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4301    1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161    2.0667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1440    2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8621    1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5803    2.0667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2943    1.6534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0125    2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0125    2.8934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2943    3.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5803    2.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8621    0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5803    0.4133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5803   -0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2943   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8621   -0.8267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1440    0.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4237    2.6512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8621    3.3068    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5970    1.4821    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0125   -1.2359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7306   -1.6451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  2  0
  4 14  1  0
 14 15  1  0
  3 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 26 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 31 36  1  0
 30 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 39 41  2  0
 37 42  2  0
 25 42  1  0
 24 43  2  0
 20 43  1  0
 33 44  1  0
 36 44  1  0
 36 45  1  1
 33 46  1  1
 40 47  3  0
 47 48  1  0
M  END

Associated Targets(Human)

SNU-16 (476 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RT-112 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR4 Tclin Fibroblast growth factor receptor 4 (3668 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hep 3B2 (2332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1581 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2B6 Tchem Cytochrome P450 2B6 (1338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 663.56Molecular Weight (Monoisotopic): 662.1699AlogP: 6.02#Rotatable Bonds: 8
Polar Surface Area: 104.15Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.46CX Basic pKa: 3.17CX LogP: 5.41CX LogD: 5.41
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.23Np Likeness Score: -0.16

References

1. Zhang X, Wang Y, Ji J, Si D, Bao X, Yu Z, Zhu Y, Zhao L, Li W, Liu J..  (2022)  Discovery of 1,6-Naphthyridin-2(1H)-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma.,  65  (11.0): [PMID:35635004] [10.1021/acs.jmedchem.1c01977]

Source